 | |||||
| programme | |||||
| NEWS | |||||
| AbbVie discontinues Rova-T programme AbbVie has announced the discontinuation of its Rova-T (rovalpituzumab tesirine) research and development programme, following a failure to ...
| |||||
| See more results | Edit this alert | |||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment